NCT07271550

Brief Summary

This study aims to evaluate a new Arabic version of the NAFF questionnaire, which measures foot care behaviors in adults with type 2 diabetes. Participants are adults with type 2 diabetes who will complete the questionnaire online. The study will assess how reliable and valid the Arabic version is, helping healthcare providers identify risky foot care behaviors and improve patient education.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
255

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

August 29, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 9, 2025

Completed
Last Updated

December 9, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

August 29, 2025

Last Update Submit

December 5, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Translation and adaptation

    Translation, cultural adaptation, and assessment of content validity through expert panel evaluation using a 4-point relevance scale. Content validity index calculated by dividing items rated 3-4 by total items (n=29). Values ≥0.80 considered acceptable.

    01/06/ 2021-31/07/ 2021 (2 months)

  • Descriptive data

    Participants were asked to complete the NAFF-A questionnaire in the waiting room before clinical consultation. Demographic and clinical data were collected from medical records in collaboration with attending physicians, including gender, age, educational level, residence, diabetes duration, HbA1c levels, and history of ulceration or amputation.

    01/08/2021 to 28/11/2021 (4 months)

  • Test-Retest Reliability of NAFF-A (Intraclass Correlation Coefficient)

    Assessment of temporal stability of the NAFF-A using intraclass correlation coefficient (ICC) between test and retest administrations. Values ≥0.70 indicate good reliability, with higher values indicating better temporal stability.

    Test-retest interval of 10-14 days between initial assessment and follow-up assessment.

Secondary Outcomes (4)

  • Internal consistency

    At the end of data collection

  • Criterion Validity - Correlation with Educational Level

    At the end of data collection

  • Criterion Validity - Correlation with HbA1c Levels

    At the end of data collection

  • Criterion Validity - Correlation with Ulceration Risk Stratification

    At the end of data collection

Eligibility Criteria

Age26 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with type 2 diabetes.

You may qualify if:

  • Adults diagnosed with type 2 diabetes mellitus
  • Age 26-65 years
  • Ability to read and understand Arabic
  • Receiving regular follow-up care at the endocrinology outpatient clinic

You may not qualify if:

  • Cognitive impairments affecting comprehension or self-care activities
  • Physical disabilities hindering self-care activities
  • Presence of active foot ulcers at time of enrollment
  • Bilateral lower-limb amputations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Farhat Hached University Hospital, Endocrinology Department

Sousse, Sousse Governorate, 4000, Tunisia

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Behavior

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctorante, Investigateur Principal

Study Record Dates

First Submitted

August 29, 2025

First Posted

December 9, 2025

Study Start

June 1, 2021

Primary Completion

November 30, 2021

Study Completion

November 30, 2021

Last Updated

December 9, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared publicly due to ethical constraints and participant privacy protections as per the Ethics Committee approval (CEFMS 81/2021) and Tunisian data protection regulations. Aggregate data and statistical results are available through the published manuscript. Researchers interested in collaboration may contact the principal investigator to discuss potential data sharing arrangements that comply with ethical and regulatory requirements.

Locations